1. Home
  2. CNTB vs LFT Comparison

CNTB vs LFT Comparison

Compare CNTB & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • LFT
  • Stock Information
  • Founded
  • CNTB 2012
  • LFT 2012
  • Country
  • CNTB United States
  • LFT United States
  • Employees
  • CNTB N/A
  • LFT N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • LFT Real Estate Investment Trusts
  • Sector
  • CNTB Health Care
  • LFT Real Estate
  • Exchange
  • CNTB Nasdaq
  • LFT Nasdaq
  • Market Cap
  • CNTB 114.8M
  • LFT 122.0M
  • IPO Year
  • CNTB 2021
  • LFT N/A
  • Fundamental
  • Price
  • CNTB $1.61
  • LFT $2.20
  • Analyst Decision
  • CNTB Strong Buy
  • LFT Hold
  • Analyst Count
  • CNTB 2
  • LFT 2
  • Target Price
  • CNTB $7.50
  • LFT N/A
  • AVG Volume (30 Days)
  • CNTB 147.2K
  • LFT 126.6K
  • Earning Date
  • CNTB 09-05-2025
  • LFT 11-11-2025
  • Dividend Yield
  • CNTB N/A
  • LFT 11.16%
  • EPS Growth
  • CNTB N/A
  • LFT N/A
  • EPS
  • CNTB N/A
  • LFT 0.18
  • Revenue
  • CNTB $1,965,000.00
  • LFT $25,803,999.00
  • Revenue This Year
  • CNTB N/A
  • LFT $124.75
  • Revenue Next Year
  • CNTB N/A
  • LFT N/A
  • P/E Ratio
  • CNTB N/A
  • LFT $11.95
  • Revenue Growth
  • CNTB N/A
  • LFT N/A
  • 52 Week Low
  • CNTB $1.55
  • LFT $2.05
  • 52 Week High
  • CNTB $2.20
  • LFT $2.84
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 41.96
  • LFT 45.94
  • Support Level
  • CNTB $1.55
  • LFT $2.12
  • Resistance Level
  • CNTB $1.76
  • LFT $2.37
  • Average True Range (ATR)
  • CNTB 0.18
  • LFT 0.06
  • MACD
  • CNTB -0.03
  • LFT -0.01
  • Stochastic Oscillator
  • CNTB 9.23
  • LFT 32.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About LFT Lument Finance Trust Inc.

Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.

Share on Social Networks: